We want to hear from you.

NC TraCS is now on Twitter and Facebook. Be the first to access breaking news and event registration and use these forums as a place to connect with others doing research in your area.

The Protein Sleuth

Scientists thought the gene SFRP2 suppressed tumor growth. Nancy Klauber-DeMore at UNC proved them wrong and created a potential breast cancer drug in the process.

PCORI Awards UNC School of Medicine Researchers More Than $2 Million for Study

NC TraCS Pilot Program Funds Investigators from Multiple Schools and Diverse Disciplines

International Consortium Exploring Long-term Outcomes of Treating Hepatitis C Releases First Data

Transcription Factors Regulating Blood Oxygen Linked to Melanoma Metastases

By A Web Design Company

The North Carolina Clinical and Translational Sciences (NC TraCS) Institute is one of 60 medical research institutions working together as a national consortium to improve the way biomedical research is conducted across the country. The consortium, funded through Clinical and Translational Science Awards (CTSA), shares a common vision to reduce the time it takes for laboratory discoveries to become treatments for patients, and to engage communities in clinical research efforts. It also is fulfilling the critical need to train a new generation of clinical researchers. The CTSA program is led by the National Center for Research Resources, part of the National Institutes of Health. For more information about NC TraCS programs and services, and the UNC-CH CTSA, call us at 919.966.6022, email us at nctracs@unc.edu, or visit us online at tracs.unc.edu